|
Status |
Public on Jun 04, 2013 |
Title |
MelJuSo un-treated H3K4me3 ChIP-seq |
Sample type |
SRA |
|
|
Source name |
MelJuSo cells
|
Organism |
Homo sapiens |
Characteristics |
cell type: Human skin melanoma cell line treatment: Un-treated time point: control cell line: MelJuSo chip antibody: H3K4me3 chip antibody manufacturer: Abcam chip antibody catalog #: ab1012 chip antibody lot #: 814968
|
Treatment protocol |
Cells were treated with indicated drugs for 2 hours and followed by extensive washing . Cells were further cultured for another 24 hours before cells were fixed and subjected for ChIP procedures.
|
Growth protocol |
Cells were grown in 15cm dishes around 80% confluency.
|
Extracted molecule |
genomic DNA |
Extraction protocol |
After fixation, lysates were cleared from sonicated nuclei and antibodies against H3K4me3 were used to IP the histone-DNA complexes. Libraries were prepared according to the provider’s kits and protocols for ChIP samples.
|
|
|
Library strategy |
ChIP-Seq |
Library source |
genomic |
Library selection |
ChIP |
Instrument model |
Illumina Genome Analyzer IIx |
|
|
Description |
Chromatin IP against H3K4me3
|
Data processing |
Reads were aligned to hg19 using BWA, duplicates and reads with mapping quality less than 60 were removed. Peaks: Peak detection was performed with the Model-based Analysis of ChIP-Seq (MACS) algorithm with default parameter.
|
|
|
Submission date |
Nov 11, 2011 |
Last update date |
May 15, 2019 |
Contact name |
Baoxu Pang |
Organization name |
Stanford University
|
Department |
Genetics
|
Lab |
Michael Snyder
|
Street address |
3165 Porter Drive
|
City |
Palo Alto |
State/province |
CALIFORNIA |
ZIP/Postal code |
94304 |
Country |
USA |
|
|
Platform ID |
GPL10999 |
Series (2) |
GSE33633 |
Epigenetic changes due to histone eviction induced by anthracycline doxorubicin and aclarubicin |
GSE33634 |
Topoisomerase II inhibitors and histone eviction |
|
Relations |
SRA |
SRX105597 |
BioSample |
SAMN00754062 |